AXIS Capital Limited (AXS)
NYSE: AXS
· Real-Time Price · USD
100.60
0.87 (0.87%)
At close: May 23, 2025, 3:59 PM
100.94
0.34%
After-hours: May 23, 2025, 05:32 PM EDT
AXIS Capital Revenue Breakdown
Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Insurance Revenue | 3.93B | 3.46B | 3.13B | 2.65B | 2.3B | 2.19B | 2.36B | 2.11B | 1.78B | 1.8B | 1.83B | 1.72B | 1.56B |
Insurance Revenue Growth | +13.41% | +10.45% | +18.21% | +15.32% | +4.97% | -7.30% | +12.17% | +18.51% | -1.16% | -1.77% | +6.26% | +10.57% | n/a |
Reinsurance Revenue | 1.38B | 1.62B | 2.03B | 2.06B | 2.07B | 2.4B | 2.43B | 2.04B | 1.93B | 1.89B | 2.04B | 1.98B | 1.86B |
Reinsurance Revenue Growth | -14.91% | -19.94% | -1.57% | -0.66% | -13.55% | -1.31% | +18.92% | +5.92% | +2.12% | -7.46% | +2.83% | +6.83% | n/a |
Operating Expense Breakdown
Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Selling, General, and Administrative Revenue | 159.16M | 189.19M | 165.2M | 148.44M | 163.37M | 169.85M | 179.28M | 168.5M | 166.81M | 187.47M | 158.25M | 165.59M | 169.04M | 184.48M | 157.96M | 162.45M | 158.41M | 143.25M | 138.82M | 140.65M | 157.06M | 138.82M | 155.52M | 165.4M | 175.09M | 23.15M | 154.89M | 165.21M | 169.84M | 32.02M | 27.93M | 147.82M | 39.46M | 33.09M | 142.91M | 146.75M | 26.31M | 140.37M | 23.6M | 148.48M | 36.17M |
Selling, General, and Administrative Revenue Growth | -15.87% | +14.52% | +11.29% | -9.14% | -3.81% | -5.26% | +6.40% | +1.01% | -11.02% | +18.47% | -4.43% | -2.04% | -8.37% | +16.79% | -2.77% | +2.55% | +10.58% | +3.19% | -1.30% | -10.45% | +13.14% | -10.74% | -5.97% | -5.54% | +656.27% | -85.05% | -6.25% | -2.72% | +430.36% | +14.64% | -81.10% | +274.61% | +19.23% | -76.84% | -2.62% | +457.72% | -81.26% | +494.69% | -84.10% | +310.49% | n/a |
Research and Development Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Research and Development Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |